5 Takeaways As Trump Eyes Cut To Medicare Drug Payments

By Jeff Overley (October 25, 2018, 11:10 PM EDT) -- The Trump administration on Thursday proposed slashing Medicare drug reimbursement to more closely align with lower prices abroad, drawing immediate fire from drugmakers and raising questions about financial fallout for hospitals.

The proposal from the Centers for Medicare & Medicaid Services emerged in a so-called advance notice of proposed rulemaking that sets the stage for a proposed rule in spring 2019 and implementation in spring 2020. The cuts would be enacted as a demonstration project that doesn't need congressional approval, although there are questions about the administration's authority for such a project.

Here, Law360 examines five takeaways from the plan....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!